Skip to main content

From Lab to City: Inside New Haven's Bid to Become a Talent Hub for the Next Generation of Innovation

Date:
10/23/2026

From Lab to City: Inside New Haven's Bid to Become a Talent Hub for the Next Generation of Innovation

Image
101 College

By: Michelle Cheon, Yale College '28
 

The stretch of land connecting downtown New Haven to its medical district was, for decades, a patchwork of parking lots. Today, that same corridor is one of the fastest-growing bioscience clusters on the East Coast. The towers at 100 and 101 College Street together hold over a million square feet of lab and research space, housing researchers from Yale University alongside Yale spinouts like BioLabs and Alexion. 

The companies arriving are no longer limited to Yale and New Haven spinouts. In May, Unilever announced plans to build a $270 million Global Innovation Centre in New Haven, replacing its research facility in nearby Trumbull. The four-story, 200,000-square-foot building is expected to bring roughly 300 employees into the city, with the company citing New Haven’s universities, talent and growing innovation ecosystem as reasons for the move.

This investment is part of an ongoing effort to strengthen ties between university research and state funding. Students are among its clearest beneficiaries with more jobs, more internships, and a growing case for staying in New Haven.

The Ecosystem Taking Shape

New Haven's bioscience cluster has grown to over 70 companies, spanning pharmaceutical research, diagnostics, cancer therapeutics, and medical devices. The city ranks fourth per capita in bioscience patents and third in academic research and development expenditures, with the NIH directing $661 million into Greater New Haven's life sciences sector in 2024 alone. Yale University has been central to that output, spinning out, on average, ten new companies per year and producing landmark exits: Halda Therapeutics was acquired for $3.05 billion at the end of 2025.

New Haven’s ambitions increasingly extend beyond bioscience. In July, QuantumCT, a Yale and UConn-backed effort to build Connecticut's quantum technology ecosystem, was selected for a $15 million National Science Foundation award, with the potential for another $160 million over the next decade. That federal award comes on top of more than $120 million in state funding Connecticut has committed to QuantumCT, largely to launch a quantum incubator in New Haven. Together, these investments give New Haven another emerging industry around which to build research, companies and talent.

Connecticut is home to more than 1,500 life sciences establishments employing over 25,000 people, ranks fifth nationally in bioscience venture capital investment per capita, and saw its startups raise $1.6 billion in funding in 2024. New Haven itself ranks among the ten fastest-growing metropolitan areas in the country for life sciences talent.

Building the Talent Pipeline

Sustaining that momentum will depend on whether the city can build out its workforce. The Greater New Haven Chamber of Commerce has operated its Bioscience Collaborative for nearly five years, serving as a convening body that connects companies, universities, and students across the region. Its Life Science Sprints program, entering its fifth summer in 2026, coordinates internships across Connecticut's bioscience sector and organizes a shared calendar of programming: kickoff events where interns meet CEOs, company tours, lunch-and-learns, and coordinated celebrations around National Intern Day.
 

“The more companies we grow and thrive here in the center, the better off we are in attracting more and more companies to the region.”
— Anne Benowitz, Greater New Haven Chamber's VP of Economic Development and Workforce Initiatives

The Chamber is also piloting a new model to engage New Haven universities. The program connects Yale graduate students with local bioscience companies to work on specific, short-term projects—like helping with early-stage research or evaluating a product idea. The Chamber helps define the project and match students with companies, making it easier for smaller firms to bring on help without setting up a full internship.

Muriel Abeledo, Greater New Haven Chamber's Workforce Development Specialist who oversees the program, describes that for many graduate students, it is their first experience inside a company in the region; for many of the companies, it is their first engagement with a Yale graduate student at all. The vision, Muriel says, is to eventually expand the model to universities across the region.

Connecticut Innovations, which funds and advises early-stage companies in the state, is following how these workforce efforts are evolving. Marina DeThomas, talent acquisition specialist at CI, points to how “universities are now operating more of a staffing model, approaching companies with opportunities rather than waiting for applications. There’s a real partnership arising.”

Yale is also building that pipeline through Yale Ventures, which runs one of the largest student innovation programs in the region: its Associates program places students from across the university, including Yale College, the School of Management, the School of Medicine, the School of Public Health, and the Graduate School, on teams that support Yale’s venture funds, accelerators, and technology licensing. The program has grown 242% since its launch, with 396 student associates hired to date and 95 in the 2026–2027 cohort across the academic year and summer. Growth has been sharpest on the research side with the number of associates supporting faculty projects going up 400%.

New Haven internship offerings are evolving in parallel, away from the traditional summer-only structure and toward semester-embedded fellowships. On February 19, 2026, CI held its second-ever Talent Fair, and several attending companies were hosting interns for the very first time after being held back by funding constraints and a lack of familiarity with the process, rather than any shortage of interest. “It's interesting to see how easy it is to create an opportunity just by asking,” DeThomas says.

That infrastructure for early-stage companies also has a physical home. BioLabs New Haven opened in 2024, built on the idea that early-stage biotech companies shouldn’t have to burn through capital building out lab space before they’ve validated their science. The model of a shared, fully equipped co-working lab, was pioneered in Boston-Cambridge and has since expanded to biotech clusters across North America, Europe, and Japan. 

Its arrival in New Haven followed the opening of 101 College Street. BioLabs had been operating out of interim space at Yale’s West Campus since April 2022, and when the tower opened, it moved into its permanent home—a 41,000 square foot lab facility with over 60 lab benches—and became the largest BioLabs location in the United States. Today, 27 companies call it home, more than half of them Yale spinouts originating from faculty, graduate students, and postdocs. 

Among its early standouts is Revalia Bio, a Yale spinout that launched at BioLabs, has since expanded, and remains anchored in the New Haven ecosystem. Most companies that have graduated out of BioLabs have stayed in the greater New Haven area.


“The goal everyone has in mind is to plant the flag—to make it well known that yes, New Haven is the place to be if you’re a biotech or bioscience company”
— Mary Ann Melnick, Head of Operations, BioLabs New Haven

The growth is also visible in the companies already based in New Haven. In September, Invivyd—a biotech developing antibody-based treatments for infectious diseases that moved its headquarters to New Haven from the Boston area—signed a lease for roughly 33,000 square feet at 205 Church Street, more than tripling the size of its existing New Haven headquarters. 

What Comes Next

Students who have completed internships in New Haven describe a substantive professional experience. One Yale student who spent a summer on Medtronic's R&D software team at its North Haven branch describes hands-on engineering work, with encouragement to build relationships across departments and gain a broader view of how a company of that scale actually operates. What the experience also clarified, the student reflects, is what they want the surrounding environment to eventually offer: more walkable connective tissue between neighborhoods, more spontaneous social infrastructure, and more of the ambient energy that makes a city feel alive after hours.

Those observations point to a broader set of gaps that New Haven, as a mid-sized city, is still working through. The challenge, then, is not simply attracting companies to New Haven, but building an ecosystem capable of supporting them once they arrive.

More local investor presence is at the top of the list—currently, many companies are still traveling to other cities to access deal flow. Specialized scientific infrastructure is another gap: therapeutics focused startups in particular need access to in vivo research facilities that don’t yet exist at scale accessible to early-stage companies in New Haven. As the cluster of biotech companies grows, recruitment is becoming another pressure point as certain scientific roles simply aren’t available in the local talent pool yet, pushing companies to look outside the state.

For all the gaps that remain, the institutions building New Haven’s innovation economy are working together to fill them. Yale Ventures and BioLabs are working to retain spinouts, the New Haven Chamber of Commerce is coordinating internship programming and graduate student placements, and Connecticut Innovations is building a pipeline of funded companies and talent fairs. These groups are interconnected, sharing job openings, exchanging talent, and pointing students and companies toward one another. The goal, as Melnick puts it, is for New Haven to no longer have to defend itself to those larger ecosystems, but to be recognized as a competitor in its own right.
 

“The theory of change is that the more everyone in the ecosystem can envision it, create opportunities, and get to know each other — the more we can achieve that kind of growth in New Haven.”
— Muriel Abeledo, Greater New Haven Chamber of Commerce